StockData
GT Biopharma, Inc. logo

GT Biopharma, Inc. (GTBP) stock

GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.18−0.25 (-7.29%)

Close on Nov 19, 2026Market cap $143.45MP/E –Yield –

GT Biopharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

GT Biopharma's price to book ratio was 17.4× on Nov 11, 2026, against 39.8× a year earlier. Over the last 5 years it ranged from 13.9× to 481.8×, with a median of 45.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202617.4×−22.2
2025Dec 31, 202539.6×−41.6
2024Dec 31, 202481.2×+54.8
2023Dec 29, 202326.4×−18.9
2022Dec 30, 202245.3×−377.2
2019Oct 31, 2019422.6×+292.7
2018Oct 31, 2018129.9×−241.2
2017Dec 29, 2017371.0×–

More GT Biopharma figures

See a number that looks wrong?